Nicolás Roche

41.9k citations
543 papers · 14.0k · 3 hit papers · h-index 62

Impact in

    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Inhalation and Respiratory Drug Delivery
    • Respiratory Support and Mechanisms
    • Respiratory and Cough-Related Research
  • Physiology top 0.2%
    • Asthma and respiratory diseases

Papers in

    • Chronic Obstructive Pulmonary Disease (COPD) Research 194
    • Inhalation and Respiratory Drug Delivery 60
    • Respiratory Support and Mechanisms 48
    • Respiratory and Cough-Related Research 48
    • Asthma and respiratory diseases 125

Nicolás Roche

503 papers receiving 13.7k citations

Nicolás Roche's Hit Papers

Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype 2025 · 40 citations
400+3+6Years since publication100200300400500

Peers

Nicolás Roche
Comparison fields: 5 of 201
  • Pulmonary and Respiratory Medicine 7.2k
  • Physiology 3.6k
  • Rehabilitation 648
  • Issues, ethics and legal aspects 90
  • Physical Therapy, Sports Therapy and Rehabilitation 337
Replace Paul Enright with:
Paul Enright United States
Peter Schnohr Denmark
Marc Decramer Belgium
Richard Casaburi United States
Jane Khoury United States
Felip Burgos Spain
George Howard United States
Vicki Hertzberg United States
J. Hankinson United States
Wayne D. Rosamond United States
Nicolás Roche relative to Paul Enright United States Paul Enright's profile →
Citations per field
00.5×1.5×2.3×
Paul Enright · 1×
Citations per year

Countries citing papers authored by Nicolás Roche

Since Specialization
Citations

This map shows the geographic impact of Nicolás Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás Roche more than expected).

Fields of papers citing papers by Nicolás Roche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolás Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás Roche. The network helps show where Nicolás Roche may publish in the future.

Co-authors

The 25 scholars most cited alongside Nicolás Roche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicolás Roche Line = papers co-authored together Nicolás Roche links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 543 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
Hit paper breakdown →
2016552
2 2002422
3
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
Hit paper breakdown →
2018411
4 2008273
5 2010242
6 2017207
7 2000188
8 2011179
9 1998167
10 2015161
11 2019157
12 2010148
13 2016148
14 2015147
15 2014146
16 2011144
17 2020143
18 2014136
19 2014132
20 2011131

About Nicolás Roche

Nicolás Roche is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Neurology, Epidemiology and Rehabilitation, having authored 543 papers that have together received 14.0k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (194 papers), Asthma and respiratory diseases (125 papers), Inhalation and Respiratory Drug Delivery (60 papers), Respiratory Support and Mechanisms (48 papers), Respiratory and Cough-Related Research (48 papers), Botulinum Toxin and Related Neurological Disorders (36 papers), Stroke Rehabilitation and Recovery (21 papers) and Cerebral Palsy and Movement Disorders (16 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (7.2k citations), Physiology (3.6k citations), Rehabilitation (648 citations), Issues, ethics and legal aspects (90 citations) and Physical Therapy, Sports Therapy and Rehabilitation (337 citations). Nicolás Roche has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Violaine Giraud, David Price, Didier Pradon, Pierre‐Régis Burgel, Djamel Bensmaïl, T. Pérez, Pascal Chanez, Gérard Huchon, Raphaël Zory and Claus Vogelmeier. Their work appears in journals such as Respiratory Medicine, European Respiratory Journal, Respiratory Research, International Journal of COPD and Annals of Physical and Rehabilitation Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact